» Articles » PMID: 24470555

Incidence of Glioma in a Northwestern Region of England, 2006-2010

Overview
Journal Neuro Oncol
Specialties Neurology
Oncology
Date 2014 Jan 29
PMID 24470555
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Gliomas are important because they affect disproportionately high numbers of people of working age and have a poor prognosis. Neurosurgeons were concerned about a possible recent cluster of glioma cases in a northwestern region in England.

Methods: All patients aged 18-89 years in Lancashire and South Cumbria with a histologically confirmed glioma diagnosed at the Royal Preston Hospital between January 1, 2006, and December 31, 2010, were ascertained. Clinical information was extracted from hospital records. Completeness of case referral to Royal Preston Hospital was checked against the National Cancer Registry and National Brain Tumour Registry records for the same period. For a comprehensive assessment of regional incidence, age-standardized incidence rates of all gliomas diagnosed in adults (aged 15 years and older) in the study area were then compared with those for the North West region and England as a whole. Rates for the North West region in defined small area-units ("Middle Super Output Areas") were also investigated to assess any small-area variation in the region during the decade to 2010.

Results: There were 435 glioma patients from Lancashire and South Cumbria diagnosed at the Royal Preston Hospital between 2006 and 2010, with case ascertainment verified to be complete by the National Cancer Registration Service. The age-standardized incidence rate of gliomas in the study area was 7.10 per 100,000 in 2006-2010, which was minimally different from the rate for all cancer networks in England over the 10 years from 2001. Small-area analysis confirmed lack of major variation in glioma rates in the North West region of England.

Conclusion: Glioma incidence rates in England have remained stable by region and over time during the last decade.

Citing Articles

High costs, low quality of life, reduced survival, and room for improving treatment: an analysis of burden and unmet needs in glioma.

Pohlmann J, Weller M, Marcellusi A, Grabe-Heyne K, Krott-Coi L, Rabar S Front Oncol. 2024; 14:1368606.

PMID: 38571509 PMC: 10987841. DOI: 10.3389/fonc.2024.1368606.


Postoperative Magnetic Resonance Imaging (MRI) Scans for the Surgical Resection of Cranial Glial Tumors According to National Institute of Health and Care Excellence (NICE) Guidelines: A Single-Center Experience.

Kouli M, Baig A, Rampersad N, Franchini S, Upadhyaya P, Balata S Cureus. 2024; 15(12):e51037.

PMID: 38264377 PMC: 10805174. DOI: 10.7759/cureus.51037.


The global prevalence of primary central nervous system tumors: a systematic review and meta-analysis.

Salari N, Ghasemi H, Fatahian R, Mansouri K, Dokaneheifard S, Shiri M Eur J Med Res. 2023; 28(1):39.

PMID: 36670466 PMC: 9854075. DOI: 10.1186/s40001-023-01011-y.


Temporal trends in the incidence of malignant and nonmalignant primary brain and central nervous system tumors by the method of diagnosis in England, 1993-2017.

Ali U, Withrow D, Judge A, Plaha P, Darby S Neuro Oncol. 2023; 25(6):1177-1192.

PMID: 36610462 PMC: 10237429. DOI: 10.1093/neuonc/noad001.


Epidemiology and survival analyses of 333 adult glioma patients from Eastern Algeria (2008-2016).

Touati S, Djekkoun R, El-Okki M, Satta D Afr Health Sci. 2021; 20(3):1250-1258.

PMID: 33402972 PMC: 7751532. DOI: 10.4314/ahs.v20i3.29.


References
1.
Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M . Long-term survival with glioblastoma multiforme. Brain. 2007; 130(Pt 10):2596-606. DOI: 10.1093/brain/awm204. View

2.
Larjavaara S, Mantyla R, Salminen T, Haapasalo H, Raitanen J, Jaaskelainen J . Incidence of gliomas by anatomic location. Neuro Oncol. 2007; 9(3):319-25. PMC: 1907421. DOI: 10.1215/15228517-2007-016. View

3.
Crocetti E, Trama A, Stiller C, Caldarella A, Soffietti R, Jaal J . Epidemiology of glial and non-glial brain tumours in Europe. Eur J Cancer. 2012; 48(10):1532-42. DOI: 10.1016/j.ejca.2011.12.013. View

4.
Bland J, Altman D . Multiple significance tests: the Bonferroni method. BMJ. 1995; 310(6973):170. PMC: 2548561. DOI: 10.1136/bmj.310.6973.170. View

5.
Zada G, Bond A, Wang Y, Giannotta S, Deapen D . Incidence trends in the anatomic location of primary malignant brain tumors in the United States: 1992-2006. World Neurosurg. 2011; 77(3-4):518-24. DOI: 10.1016/j.wneu.2011.05.051. View